1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Mutant huntingtin expression in the hypothalamus promotes ventral striatal neuropathology
2023)(
- Working paper/Preprint › Preprint in preprint archive
- 2022
-
Mark
Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
(
- Contribution to journal › Article
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
2022)(
- Working paper/Preprint › Preprint in preprint archive
- 2021
-
Mark
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
(
- Contribution to journal › Article
- 2019
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
- 2012
-
Mark
No diagnostic value of plasma clusterin in Alzheimer's disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article